Final results of randomized study of gemcitabine (G) plus cisplatin (P) versus etoposide (E) plus cisplatin in locally advanced or metastatic non small cell lung cancer (NSCLC)

被引:0
|
作者
Bousahba, A., Sr. [1 ]
Bereksi-Reguig, F. [1 ]
Seghier, F. [1 ]
Boukerche, A. [1 ]
Dali-Youcef, A. [1 ]
Djellali, L. [1 ]
机构
[1] Natl Inst Med, Oran, Algeria
关键词
D O I
10.1200/jco.2008.26.15_suppl.19006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
19006
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Phase I/II trial of gemcitabine (G) administered every other week plus cisplatin (P) in advanced non-small cell lung cancer (NSCLC): final results
    Nelli, F
    De Marinis, F
    Ariganello, O
    Belli, R
    Cipri, A
    Diana, F
    Lampignano, M
    Paoluzzi, L
    Martelli, O
    Migliorino, MR
    Di Molfetta, M
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2002, : 410 - 411
  • [22] Analysis of the costs of bevacizumab plus cisplatin and gemcitabine versus cetuximab plus vinorelbine and cisplatin in patients with advanced non-small cell lung cancer (NSCLC) in France: Results from a cost modelling study
    Chouaid, C.
    Vergnenegre, A.
    Florentin, V.
    Walzer, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [23] Efficacy and Safety of 8 spheres Plus Cisplatin Versus Vinorelbine Plus Cisplatin in Locally Advanced Non-small Cell Lung Cancer
    Wang, Xiaojun
    Zhang, Huiyun
    Zhou, Liangfen
    Ou, Hui
    Liu, Hengyu
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2023, 38 (05) : 313 - 321
  • [24] Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan
    Ohe, Y.
    Ohashi, Y.
    Kubota, K.
    Tamura, T.
    Nakagawa, K.
    Negoro, S.
    Nishiwaki, Y.
    Saijo, N.
    Ariyoshi, Y.
    Fukuoka, M.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 (02) : 317 - 323
  • [25] Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small cell lung cancer: A phase III randomized trial
    Georgoulias, V.
    Ardavanis, A.
    Tsiafaki, X.
    Agelidou, A.
    Syrigos, K.
    Polyzos, A.
    Kakolyris, S.
    Kouroussis, Ch
    Androulakis, N.
    Chatzidaki, D.
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 169 - 169
  • [26] Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small-cell lung cancer: A phase III randomized trial
    Georgoulias, V
    Ardavanis, A
    Tsiafaki, X
    Agelidou, A
    Mixalopoulou, P
    Anagnostopoulou, O
    Ziotopoulos, P
    Toubis, M
    Syrigos, K
    Samaras, N
    Polyzos, A
    Christou, A
    Kakolyris, S
    Kouroussis, C
    Androulakis, N
    Samonis, G
    Chatzidaki, D
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (13) : 2937 - 2945
  • [27] Gemcitabine and cisplatin in advanced non small cell lung cancer (NSCLC)
    Garcia-Gomez, R
    Lopez-Criado, P
    Guevara, S
    Lahoz, C
    Chaib, C
    Gonzalez, C
    Santiago, J
    De Alvaro, J
    Carrion, R
    Perez-Manga, G
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 93 - 94
  • [28] Randomized phase III study of Gemcitabine/cisplatin versus mitomycin/ifosfamide/cisplatin in advanced non-small cell lung cancer (NSCLC)
    Scagliotti, G
    Crino, L
    Conte, PF
    Rinaldi, M
    De Marinis, F
    Gridelli, C
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 85 - 85
  • [29] Safety and Resource Utilization by Non-small Cell Lung Cancer Histology Results from the Randomized Phase III Study of Pemetrexed Plus Cisplatin versus Gemcitabine Plus Cisplatin in Chemonaive Patients with Advanced Non-small Cell Lung Cancer
    Novello, Silvia
    Pimentel, Francisco Luis
    Douillard, Jean-Yves
    O'Brien, Mary
    von Pawel, Joachim
    Eckardt, John
    Liepa, Astra M.
    Simms, Lorinda
    Visseren-Grul, Carla
    Paz-Ares, Luis
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (10) : 1602 - 1608
  • [30] RADIOTHERAPY VERSUS RADIOTHERAPY PLUS CISPLATIN TREATMENT FOR LOCALLY ADVANCED NON SMALL CELL LUNG-CANCER - PRELIMINARY-RESULTS OF A RANDOMIZED STUDY
    CLERICI, M
    SORESI, E
    ZUCALI, R
    BORGHINI, U
    VERGANI, C
    LEONI, M
    BOTTURI, F
    LUPORINI, G
    [J]. TUMORI, 1987, 73 (06) : 627 - 628